Real-world patient characteristics and survival outcomes in patients with advanced or recurrent endometrial cancer in England: a retrospective, population-based study

Real-world patient characteristics and survival outcomes in patients with advanced or recurrent endometrial cancer in England: a retrospective, population-based study

Objective This study defined a retrospective cohort of patients in England with primary advanced or recurrent (A/R) endometrial cancer (EC) who may have been eligible for clinical trials evaluating immune checkpoint inhibitors (ICIs) in the first-line (1L) setting within a real-world dataset, and de...

Full description

Saved in:

Bibliographic Details
Main Authors:	Clare Pearson, Susana Banerjee, Kiera Heffernan, Tameera Rahman, Jamie Garside, Alvaro Ingles Russo Garces
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-11-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/14/11/e083540.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Healthcare Resource Utilization and Costs Among Commercially Insured Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States
by: Monica Kobayashi, et al.
Published: (2023-11-01)

Treatment Patterns and Outcomes Among Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States
by: Robert L. Coleman, et al.
Published: (2023-10-01)

Explainable machine learning for predicting recurrence-free survival in endometrial carcinosarcoma patients
by: Samantha Bove, et al.
Published: (2024-12-01)

FIGO 2023 staging system predicts not only survival outcome but also recurrence pattern in corpus-confined endometrial cancer patients
by: Hua-Hsi Wu, et al.
Published: (2025-01-01)

A novel prognostic score of recurrence for endometrial cancer patients with staging surgery
by: Tomoka Maehana, et al.
Published: (2024-12-01)

Clinical Use of Dostarlimab in Advanced Stage and Recurrent Endometrial Cancer: Patient Selection and Perspectives
by: Bujnak AC, et al.
Published: (2025-01-01)

Surgical trends, outcomes and disparities in minimal invasive surgery for patients with endometrial cancer in England: a retrospective cohort study
by: Thomas Ind, et al.
Published: (2020-09-01)

Analysis of survival-related factors in patients with endometrial cancer using a Bayesian network model.
by: Huan Zhang, et al.
Published: (2024-01-01)

The use of propensity score matching to assess the effectiveness of the endometrial receptivity analysis in patients with recurrent implantation failure
by: Shuang Yu, et al.
Published: (2025-01-01)

Factors influencing endometrial receptivity in women with recurrent implantation failure
by: Katarzyna Opuchlik, et al.
Published: (2025-01-01)

Minority ethnicity patient satisfaction and experience: results of the National Cancer Patient Experience Survey in England
by: Henrik Moller, et al.
Published: (2016-06-01)

Epidemiological Factors in Patients with Endometrial Adenocarcinoma
by: Luis Enrique Pompa Montes de Oca, et al.
Published: (2011-11-01)

Nomograms for Predicting Overall and Cancer-Specific Survival Among Second Primary Endometrial Cancer in Primary Colorectal Carcinoma Patients
by: Liu L
Published: (2024-12-01)

Prevalence of occult endometrial carcinoma in patients with endometrial intraepithelial neoplasia who underwent hysterectomy
by: Waraphon Thongsang, et al.
Published: (2025-01-01)

Incidence, local recurrence, metastasis, disease-specific survival, and overall survival in patients with cutaneous rhabdomyosarcoma: A nationwide cohort study of 24 patients
by: S.H. Dueled, et al.
Published: (2024-01-01)

Systematic review of prognostic models for predicting recurrence and survival in patients with treated oropharyngeal cancer
by: Janine Dretzke, et al.
Published: (2024-12-01)

Controversies in the Management of Endometrial Cancer
by: V. Masciullo, et al.
Published: (2010-01-01)

Smoking recurrence: A Survival Analysis
by: Ana Beatriz Ramos da Silva, et al.
Published: (2024-12-01)

Immune Checkpoint Inhibitors in Endometrial Cancer: The New Paradigm of Treatment for Advanced and Recurrent Disease
by: Marta Nerone, et al.
Published: (2023-12-01)

Generation and Maintenance of Patient-Derived Endometrial Cancer Organoids
by: Mali Barbi, et al.
Published: (2024-10-01)

The new FIGO 2023 staging reclassification of patients with FIGO 2009 Stage IVB endometrial cancer correlates to progression-free and overall survival outcomes
by: Monal Garg, et al.
Published: (2024-12-01)

Real-world overall survival in second-line maintenance niraparib monotherapy versus active surveillance in patients with wild-type recurrent ovarian cancer
by: Robert L. Coleman, et al.
Published: (2024-11-01)

Outcomes for Dostarlimab and Real-World Treatments in Post-platinum Patients With Advanced/Recurrent Endometrial Cancer: The GARNET Trial Versus a US Electronic Health Record-Based External Control Arm
by: Scott Goulden, et al.
Published: (2023-09-01)

The Impact of p53 and Ki67 Expression in Endometrial Cancer and its Effect on Survival
by: Zekiye Sahin, et al.
Published: (2022-03-01)

Extended Survival and Prognostic Factors in Endometrial Cancer: A Multivariate Cox Regression Analysis
by: Irene Valencia Téllez, et al.
Published: (2024-12-01)

The inflammatory markers combined with CA125 may predict postoperative survival in endometrial cancer
by: Hongxing Lin, et al.
Published: (2024-12-01)

The role of sarcopenia on survival outcomes in endometrial cancer: A systematic review and meta-analysis
by: Man Zhang, et al.
Published: (2025-02-01)

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study
by: Emiel A. De Jaeghere, et al.
Published: (2022-08-01)

Conservative Resolution of a Vesicovaginal Fistula Including Laser Therapy in a Patient Who Underwent Recurrent Surgery After Prior Radiotherapy for Endometrial Cancer
by: Alessandro Buda, et al.
Published: (2024-11-01)

Comparison of clinico-pathological characteristics and survival of recurrent ovarian cancer patients on seven different chemo-protocols
by: Sattar Saima, et al.
Published: (2019-03-01)

Prognosis of Gastric Cancer Patients with Node-Negative Metastasis following Curative Resection: Outcomes of the Survival and Recurrence
by: Jingyu Deng, et al.
Published: (2008-01-01)

Unusual Presentation of Recurrent Early Stage Endometrial Carcinoma 28 Years after Primary Surgery
by: Alessandro Franchello, et al.
Published: (2015-01-01)

Bidirectional recurrent neural network approach for predicting cervical cancer recurrence and survival
by: S. Geeitha, et al.
Published: (2024-12-01)

Differential characteristics of vaginal versus endometrial microbiota in IVF patients
by: Alina Polifke, et al.
Published: (2024-12-01)

Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study
by: Emiel A. De Jaeghere, et al.
Published: (2024-12-01)

Impact of re-operation on progression-free survival in patients with recurrent GBM: Experience in a tertiary referral center.
by: Houssein Darwish, et al.
Published: (2025-01-01)

Multiomic quantification of the KRAS mutation dosage improves the preoperative prediction of survival and recurrence in patients with pancreatic ductal adenocarcinoma
by: Won-Gun Yun, et al.
Published: (2025-01-01)

Lenvatinib and pembrolizumab versus platinum doublet chemotherapy as second-line therapy for advanced or recurrent endometrial cancer
by: Yutaka Yoneoka, et al.
Published: (2024-11-01)

Endometrial Atypical Hyperplasia and Risk of Endometrial Cancer
by: An-Ju Chou, et al.
Published: (2024-11-01)

Cervical cancer mortality trends in England and Poland
by: Clare Gilham, et al.
Published: (2024-12-01)